Acupuncture for Carpal Tunnel Syndrome
Launched by GEORGE WASHINGTON UNIVERSITY · Nov 3, 1999
Trial Information
Current as of March 18, 2025
Completed
Keywords
ClinConnect Summary
This is a randomized, double-blind, controlled trial of acupuncture for carpal tunnel syndrome (CTS). The study's aims are: (1) To show that we can develop a "single-blind mute" methodology that will enable true and alternative acupuncture to be given in a standardized and unbiased fashion. (2) To identify and standardize the most appropriate invasive control (alternative) acupuncture points for CTS. (3) To develop a manual of acupuncture methods that codifies the techniques of administration of true and alternative points that can be used at any site performing a randomized clinical trial ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hand or wrist pain combined with parathesias or numbness in any or all fingers, predominating in a median nerve distribution, and especially occurring at night
- • Symptoms unresponsive or poorly responsive to standard conservative therapy (wrist splints, analgesics, nonsteroidal anti-inflammatory drugs)
- • Electrodiagnostic evidence of distal median neuropathy compatible with carpal tunnel syndrome (to be confirmed at study site)
- • Symptoms present for at least 3 months
- • No prior treatment with acupuncture for carpal tunnel syndrome
- Exclusion Criteria:
- • Evidence of pronounced abductor pollicis weakness or significant thenar wasting (probable candidate for carpal tunnel surgery)
- • Prior carpal tunnel surgery on affected side
- • Use of narcotic analgesia
- • History of wrist or hand fracture on the symptomatic limb
- • Current pregnancy or less than 3 months postpartum
- • Corticosteroid injection into the carpal tunnel within 3 months
- • History of generalized peripheral neuropathy or clinical or electrodiagnostic evidence of generalized polyneuropathy or mononeuropathy multiplex
- • History of other neurologic disorders which may cause confusion with the diagnosis of carpal tunnel syndrome, including but not limited to stroke, cervical radiculopathy, myelopathy, subdural hematoma, brain tumor
- • Inflammatory articular disease or tendinitis of the hand or wrist by history or physical examination
- • Insulin-dependent diabetes mellitus
- • Clinical hypothyroidism
- • Chronic renal failure or renal dialysis or forearm fistulae
- • Other disorder known to predispose to carpal tunnel syndrome including acromegaly, multiple myeloma, amyloidosis
Trial Officials
Arthur Weinstein, M.D.
Principal Investigator
The George Washington University Medical Center
About George Washington University
George Washington University (GWU) is a leading academic institution dedicated to advancing medical research and education. As a clinical trial sponsor, GWU leverages its extensive resources and expertise to facilitate innovative studies that aim to improve healthcare outcomes. The university's commitment to ethical research practices, collaboration with multidisciplinary teams, and engagement with diverse populations underscores its role in addressing critical health challenges. By fostering a rigorous scientific environment, GWU strives to translate research findings into effective clinical applications, ultimately enhancing patient care and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials